Multiple Sclerosis Journal - Experimental Translational and Clinical,
Journal Year:
2024,
Volume and Issue:
10(4)
Published: Oct. 1, 2024
Background
Multiple
sclerosis
(MS)
is
an
autoimmune
condition
characterized
by
inflammatory
and
neurodegenerative
traits.
Recently,
DNA
methylation
has
emerged
as
a
promising
field
of
investigation
for
elucidating
dynamics
characterizing
MS
development
progression.
Objectives
This
study
aimed
to
comprehensively
investigate
the
role
epigenetics
in
analyzing
profiles
from
blood
brain
tissues
public
datasets.
Methods
Employing
meta-analytical
framework
differential
analyses,
extended
beyond
conventional
analyses
explore
additional
dimensions
epigenetic
regulation,
including
drift,
age
acceleration,
rare
epivariations.
Results
analysis
were
line
with
previously
reported
findings.
No
significant
differences
observed
acceleration
or
global
drift
between
cases
controls.
However,
upon
closer
at
gene
level,
distinctive
patterns
emerged,
particularly
within
genes
implicated
neural
biological
functions.
Conclusions
These
findings
underscore
modifications
shaping
pathology.
Furthermore,
unveiled
exclusive
presence
epivariations
cases,
some
which
involved
linked
other
diseases.
highlights
potential
significance
genetic
aberrations
driving
susceptibility
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 28, 2025
Abstract
Human
lifespan
is
shaped
by
genetic
and
environmental
factors.
To
enable
precision
health,
understanding
how
variants
influence
mortality
essential.
We
conducted
a
survival
analysis
in
European
ancestry
participants
of
the
UK
Biobank,
using
age-at-death
(N=35,551)
last-known-age
(N=358,282).
The
associations
identified
were
predominantly
driven
cancer.
found
lifespan-associated
loci
(
APOE
,
ZSCAN23
)
for
common
six
genes
where
burden
loss-of-function
linked
to
reduced
TET2
ATM
BRCA2
CKMT1B
BRCA1
ASXL1
).
Additionally,
eight
with
pathogenic
missense
associated
DNMT3A,
SF3B1,
TET2,
PTEN,
SOX21,
TP53
SRSF2
RLIM
Many
these
are
involved
oncogenic
pathways
clonal
hematopoiesis.
Our
findings
highlight
importance
factors
driving
most
prevalent
causes
at
population
level,
highlighting
potential
early
testing
identify
germline
somatic
increasing
one’s
susceptibility
cancer
and/or
death.
Frontiers in Molecular Biosciences,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 7, 2025
Emerging
evidence
underscores
the
comorbidity
mechanisms
among
autoimmune
diseases
(AIDs),
with
innovative
technologies
such
as
single-cell
RNA
sequencing
(scRNA-seq)
significantly
advancing
explorations
in
this
field.
This
study
aimed
to
investigate
shared
genes
three
AIDs-Multiple
Sclerosis
(MS),
Systemic
Lupus
Erythematosus
(SLE),
and
Rheumatoid
Arthritis
(RA)
using
bioinformatics
databases,
identify
potential
biomarkers
for
early
diagnosis.
We
retrieved
transcriptomic
data
of
MS,
SLE,
RA
patients
from
public
databases.
Weighted
Gene
Co-Expression
Network
Analysis
(WGCNA)
was
employed
construct
gene
co-expression
networks
disease-associated
modules.
Functional
enrichment
analyses
Protein-Protein
Interaction
(PPI)
network
constructed.
used
machine
learning
algorithms
select
candidate
evaluate
their
diagnostic
value.
The
Cibersort
algorithm
scRNA-seq
analysis
performed
key
expression
patterns
assess
infiltration
immune
cells
MS
patients.
Finally,
biomarkers'
validated
human
mice
experiments.
Several
were
identified,
which
play
crucial
roles
responses
inflammation
regulation.
PPI
highlighted
hub
genes,
some
selected
through
algorithms.
Receiver
Operating
Characteristic
(ROC)
curve
indicated
that
had
high
value
(Area
Under
Curve,
AUC
>0.7).
Immune
cell
pattern
showed
significant
differences
various
revealed
clusters
upregulated
single
cerebrospinal
fluid
EAE
mose
model.
Validation
clinical
samples
confirmed
biomarkers.
identified
proposed
These
are
pivotal
regulating
responses,
providing
new
targets
theoretical
basis
diagnosis
treatment
diseases.
European Journal of Neurology,
Journal Year:
2025,
Volume and Issue:
32(4)
Published: March 30, 2025
ABSTRACT
Background
Identifying
predictors
for
disability
progression
is
crucial
managing
multiple
sclerosis
(MS).
This
study
aims
to
explore
levels
of
and
informative
factors
in
people
with
MS
(PwMS)
using
healthcare
data
without
detailed
clinical
information.
Methods
We
conducted
a
case–control/cohort
on
from
Bavaria's
largest
health
insurance
organization.
The
dataset
included
records
assistive
devices,
nursing
care,
sick
leaves,
rehabilitation,
drug
therapies,
diagnoses
individuals
MS,
Crohn's
disease
(CD),
rheumatoid
arthritis
(RA),
controls
(CTR)
these
diseases.
used
generalized
linear
models
compare
service
utilization
between
other
cohorts.
A
gradient‐boosting
algorithm
identified
healthcare‐related
associated
PwMS,
defined
by
increased
care
utilization.
Results
PwMS
(
N
=
11,961)
demonstrated
higher
than
CD
21,884),
RA
105,450),
CTR
82,677)
groups,
even
at
young
ages.
Besides
expected
risk
like
age,
smoking,
diabetes,
psychiatric
disorders,
the
prediction
revealed
that
specific
gynecological
upper
tract
infections,
asthma,
thyroiditis
were
less
likely
need
care.
Conclusions
Leveraging
allows
an
objective
assessment
can
identify
progression.
Our
approach
be
applied
studies
large
cohorts
adapted
diseases,
measures,
systems.
Higher
resources
ages
unmet
improved
treatment
management
strategies
adults
MS.
Journal of Autoimmunity,
Journal Year:
2024,
Volume and Issue:
148, P. 103294 - 103294
Published: July 30, 2024
While
multiple
sclerosis
(MS)
affects
less
than
1
%
of
the
general
population,
immune
mediated
inflammatory
diseases
(IMIDs)
collectively
influence
5-10
population.
Understanding
familial
co-aggregation
MS
and
other
IMIDs
carries
important
clinical
public
health
implications
that
will
enable
early
detection
personalized
treatment.
Pharmacy & Pharmacology,
Journal Year:
2024,
Volume and Issue:
11(5), P. 422 - 431
Published: Jan. 29, 2024
Rheumatoid
arthritis
(RA)
is
a
systemic
inflammatory
disease
affecting
mainly
small
and
major
joints.
The
development
for
new
drugs
the
treatment
of
RAs
constantly
underway,
while
purposeful
synthesis
multi-targeted
molecules
can
be
considered
promising
direction
anti-rheumatic
drugs.
aim.
To
evaluate
anti-inflammatory
antiresorptive
effects
acyl
substituted
chromone
derivatives
in
experimental
animal
model
rheumatoid
arthritis.
Materials
methods.
RА
was
modeled
rats
by
injection
suspension
human
type
II
collagen
complete
Freunds
adjuvant
(in
ratio
1:1)
under
plantar
aponeurosis
hind
limb
animal.
analyzed
substances
ciphers
X3A7
X3A9
at
dose
20
mg/kg
reference
drug
dexamethasone
3
were
administered
intraperitoneally
28
days
from
moment
RA
modeling.
On
7
th
,
14
21
st
experiment,
severity
clinical
manifestations
determined.
After
days,
changes
content
cytokines
blood
serum
assessed:
tumor
necrosis
factor-α
(TNF-α),
interleukins
(IL-1,
IL-6,
IL-10
IL-12).
Changes
myeloperoxidase
activity
concentrations
matrix
metalloproteinases
(MMPs)
2
9
determined
synovial
tissues.
Results.
During
study,
it
shown
that
use
tested
compounds
X3A9,
as
well
reference,
contributed
to
decrease
RA,
starting
day
experiment.
Subsequently,
demonstrated
animals
treated
with
dexamethasone,
cytokine
decreased
relation
untreated
animals:
TNF-α
–
57.8%
(
p
<
0.05),
IL-1
64.1%
IL-6
59.1%
0.05)
IL-12
72.3%
an
increase
level
75.4%
0.05).
profile
changed
similarly
when
studied
animals.
It
worth
noting
against
background
administration
substances,
41.7
61.7
65.0%
respectively,
concentration
MMP2
24.0
38.5
34.4%
MMP9
13.5
37.9
35.6%
Conclusion.
study
showed
suppresses
reactions
resorptive
processes
tissues,
which
serve
basis
their
further
antirheumatic
agents.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 21, 2024
Abstract
Background
To
identify
rheumatoid
arthritis
(RA)-associated
susceptibility
genes
and
pathways
through
integrating
genome-wide
association
study
(GWAS)
self-collected
gene
expression
profile
data.
Methods
A
prediction
model
was
built
for
synovium
in
202
arthritic
patients
with
matched
genotype
Using
the
FUSION
software
performed
a
transcriptome-wide
(TWAS).
GWAS
summary
data
driven
from
largest
RA
meta-analysis
(n
=
276,020).
Further
analyses
(conditional
joint
analysis,
two
types
of
causal
differential
analysis
gene-set
enrichment
analysis)
were
used
to
deepen
our
understanding
genetic
architecture
comorbidity
aetiology
RA.
Results
We
identified
eight
conditionally
independent
associated
after
Bonferroni
corrections,
which
three
novel,
such
as
TPRA1
(
P
TWAS
9.59
×
10
−
6
)
HIP1
1.47
5
).
four
that
showed
strong
evidence,
differentially
expressed
RA,
explored
possibility
new
uses
known
drugs.
Conclusions
By
using
relevant
tissues
synovium,
led
identification
previously
unknown
RA-associated
genes,
shedding
light
on
underlying